Treatment of agitation in Alzheimer disease, text messaging for CV risk modification, a newly approved PCSK9 inhibitor for dyslipidemia, and more.
- Author
- American Medical Association
- Published
- Tue 22 Sep 2015
- Episode Link
- http://dx.doi.org/10.1001/jama.2014.11991
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the September 22/29, 2015 issue
